Effect of Colostrum on Gut Permeability and Endotoxin Level in Chronic Alcoholic Disease
NCT01088087 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2010-03-17
Summary
Chronic alcohol ingestion is related with leaky gut syndrome. Colostrum is well-studied that it has a effect of decreasing the degree of leaky gut syndrome.
So the investigators are planning to find out whether Colostrum has a effect of decreasing the degree of leaky gut syndrome.
Conditions
- Leaky Gut Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
colostrum
colostrum, 2g, 2 times a day, for 3 weeks
Sponsors & Collaborators
-
Cell Biotech Co., Ltd.
collaborator INDUSTRY -
Gangnam Severance Hospital
lead OTHER
Principal Investigators
-
Jae Yong Shim, Master · Gangnam Severance Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-03-31
- Primary Completion
- 2010-09-30
- Completion
- 2010-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Application and Effect Evaluation of Medium Chain Fatty Acid Rich Milk Powder in Infants With Cholestatic Liver Disease
NCT05922332 ·Status: WITHDRAWN ·Phase: NA
-
Safety of Undenatured Collagen Type II (UCII) Supplement in Healthy Volunteer
NCT05002634 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis
NCT01968382 ·Status: COMPLETED ·Phase: PHASE2
-
Zinc and Copper Absorption in Neonates With Bilious Losses
NCT00738283 ·Status: COMPLETED
-
Nutritional Assessment Tool and Nutritional Intervention in Childhood Chronic Liver Disease
NCT02715973 ·Status: COMPLETED ·Phase: NA
-
The Effect of Physical Properties of Lipid Emulsions on Gastrointestinal Function
NCT01253005 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
NCT00004347 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life
NCT01008293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
NCT01555957 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
NCT06425380 ·Status: RECRUITING ·Phase: NA
-
Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease
NCT06512701 ·Status: RECRUITING
-
Effect of Coconut Milk Supplementation to Improve Nutritional Status in Cirrhosis Patient
NCT03354299 ·Status: COMPLETED ·Phase: NA
-
Dietary Glycine Supplementation in Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07285135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples (MICRONACH)
NCT02650115 ·Status: COMPLETED
-
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
NCT00006061 ·Status: COMPLETED ·Phase: NA
-
Intralumenal Effects on Cholesterol Absorption/Synthesis
NCT00328211 ·Status: COMPLETED ·Phase: NA
-
Cholestasis Prevention: Efficacy of IV Fish Oil
NCT00512629 ·Status: COMPLETED ·Phase: PHASE1
-
Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients
NCT05279586 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis
NCT01922895 ·Status: TERMINATED ·Phase: NA
-
Cross-linked Emulsion Study
NCT01333020 ·Status: COMPLETED ·Phase: NA
-
BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
NCT06538077 ·Status: RECRUITING ·Phase: PHASE4
-
Gastric Emptying and Gallbladder Motility Study
NCT00940849 ·Status: COMPLETED ·Phase: NA
-
Crassostrea Gigas for Liver Health
NCT02992470 ·Status: UNKNOWN ·Phase: NA
-
S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE
NCT01446523 ·Status: COMPLETED ·Phase: NA
-
A Trial of Taurine Supplementation in Parenteral Nutrition 1
NCT00135044 ·Status: UNKNOWN ·Phase: NA